BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23220403)

  • 1. Modelling fibrinolysis: a 3D stochastic multiscale model.
    Bannish BE; Keener JP; Fogelson AL
    Math Med Biol; 2014 Mar; 31(1):17-44. PubMed ID: 23220403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling fibrinolysis: 1D continuum models.
    Bannish BE; Keener JP; Woodbury M; Weisel JW; Fogelson AL
    Math Med Biol; 2014 Mar; 31(1):45-64. PubMed ID: 23220467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of plasmin-mediated degradation on fibrinolysis and tissue plasminogen activator diffusion.
    Bannish BE; Paynter B; Risman RA; Shroff M; Tutwiler V
    Biophys J; 2024 Mar; 123(5):610-621. PubMed ID: 38356261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An experimental and theoretical study on the dissolution of mural fibrin clots by tissue-type plasminogen activator.
    Wootton DM; Popel AS; Alevriadou BR
    Biotechnol Bioeng; 2002 Feb; 77(4):405-19. PubMed ID: 11787013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and Physical Mechanisms of Fibrinolysis and Thrombolysis from Mathematical Modeling and Experiments.
    Bannish BE; Chernysh IN; Keener JP; Fogelson AL; Weisel JW
    Sci Rep; 2017 Aug; 7(1):6914. PubMed ID: 28785035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inner clot diffusion and permeation during fibrinolysis.
    Diamond SL; Anand S
    Biophys J; 1993 Dec; 65(6):2622-43. PubMed ID: 8312497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced fibrinolysis by proteolysed coagulation factor Xa.
    Talbot K; Meixner SC; Pryzdial EL
    Biochim Biophys Acta; 2010 Apr; 1804(4):723-30. PubMed ID: 19931652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-ordinated spatial propagation of blood plasma clotting and fibrinolytic fronts.
    Zhalyalov AS; Panteleev MA; Gracheva MA; Ataullakhanov FI; Shibeko AM
    PLoS One; 2017; 12(7):e0180668. PubMed ID: 28686711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
    Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies.
    Longstaff C; Thelwell C; Williams SC; Silva MM; Szabó L; Kolev K
    Blood; 2011 Jan; 117(2):661-8. PubMed ID: 20966169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and biophysical conditions for blood clot lysis.
    Sabovic M; Blinc A
    Pflugers Arch; 2000; 440(5 Suppl):R134-6. PubMed ID: 11005642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and biophysical conditions for blood clot lysis.
    Šabovič M; Blinc A
    Pflugers Arch; 2000 Jan; 440(Suppl 1):R134-R136. PubMed ID: 28008511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of activated coagulation factor XII in overall clot stability and fibrinolysis.
    Konings J; Hoving LR; Ariëns RS; Hethershaw EL; Ninivaggi M; Hardy LJ; de Laat B; Ten Cate H; Philippou H; Govers-Riemslag JW
    Thromb Res; 2015 Aug; 136(2):474-80. PubMed ID: 26153047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin-specific and effective clot lysis requires both plasminogen activators and for them to be in a sequential rather than simultaneous combination.
    Pannell R; Li S; Gurewich V
    J Thromb Thrombolysis; 2017 Aug; 44(2):210-215. PubMed ID: 28600623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breaking the fibrinolytic speed limit with microwheel co-delivery of tissue plasminogen activator and plasminogen.
    Disharoon D; Trewyn BG; Herson PS; Marr DWM; Neeves KB
    J Thromb Haemost; 2022 Feb; 20(2):486-497. PubMed ID: 34882946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of clot contraction on clot degradation: A mathematical and experimental approach.
    Risman RA; Abdelhamid A; Weisel JW; Bannish BE; Tutwiler V
    Biophys J; 2022 Sep; 121(17):3271-3285. PubMed ID: 35927957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clot penetration and retention by plasminogen activators promote fibrinolysis.
    Marcos-Contreras OA; Ganguly K; Yamamoto A; Shlansky-Goldberg R; Cines DB; Muzykantov VR; Murciano JC
    Biochem Pharmacol; 2013 Jan; 85(2):216-22. PubMed ID: 23098998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin.
    Mutch NJ; Engel R; Uitte de Willige S; Philippou H; Ariëns RA
    Blood; 2010 May; 115(19):3980-8. PubMed ID: 20228273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A precise and rapid microtitre plate clot lysis assay: methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis.
    Jones AJ; Meunier AM
    Thromb Haemost; 1990 Nov; 64(3):455-63. PubMed ID: 2128976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment.
    Varjú I; Longstaff C; Szabó L; Farkas ÁZ; Varga-Szabó VJ; Tanka-Salamon A; Machovich R; Kolev K
    Thromb Haemost; 2015 Jun; 113(6):1289-98. PubMed ID: 25789443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.